查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1844194

整形外科软组织修復市场（按产品类型、应用、最终用户、手术类型和材料划分）－2025-2032年全球预测

Orthopedic Soft Tissue Repair Market by Product Type, Application, End User, Surgery Type, Material - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，整形外科软组织修復市场规模将成长 235.3 亿美元，复合年增长率为 16.18%。

关键市场统计数据
基准年 2024 70.8亿美元
预计年份：2025年 82.4亿美元
预测年份 2032 235.3亿美元
复合年增长率 (%) 16.18%

本入门架构旨在向企业主管介绍影响整形外科软组织修復生态系统的临床促进要素、产品系列和商业性槓桿。

本执行摘要重点在于当代整形外科软组织修復领域，着重阐述临床、技术和商业性因素如何重塑治疗路径。过去十年，临床医生和製造商在材料科学、微创技术和生物活性构建体方面不断达成共识，对肌腱和韧带病变的修復策略有了更深入的理解。本概要概述了主要产品系列、手术方法和终端用户环境，并分析了市场应用动态和采购重点，以此组装本报告的范围。

引言部分阐述了临床医生偏好、报销驱动因素和器械创新之间的相互关联，帮助读者理解为何某些材料和锚固设计能够获得广泛应用，而其他解决方案则需要不断迭代改进。这一方向阐明了临床证据开发与商业性执行之间的相互关係，重点强调了差异化的临床结果和易用性如何影响医院采购委员会和门诊手术中心的合约。因此，策略领导者会发现本引言部分可作为后续蓝图环境。

总而言之，开篇部分阐述了决策者理解后续关于整形外科软组织修復的竞争定位、监管变化和通路策略的讨论所必需的术语和市场结构。

对推动整形外科软组织修復实务和采购快速发展的技术、临床和商业性曲折点进行简要分析。

生医材料、外科技术和以价值为导向的医疗模式的进步正在改变整形外科软组织修復的格局。支架化学和生物增强技术的创新正在拓展临床选择，而缝合锚钉动态性能的提升和微创器材的改进则正在减少术中併发症。能够缩短手术时间、提供可重复的固定强度并促进与自体组织整合的材料正日益成为不可或缺的选择。

此外，不断变化的医保报销环境以及对门诊治疗路径的重视，促使人们寻求能够在降低总治疗费用的同时，提供稳定疗效的解决方案。因此，製造商正优先进行以疗效比较和真实世界结果为重点的证据研究，以支持产品纳入健保目录和医院认证。同时，供应链的考量以及医院集团内部的器械整合，也迫使商业团队重新思考其价值提案和合约策略。

总而言之，这些转变正在引发一场竞争格局的转变，即从单一功能竞争转向整合设备性能、临床培训和疗效支持的综合生态系统竞争。对于製造商和医疗系统领导者而言，当务之急显而易见：将产品创新与可靠的临床数据和切合实际的经济效益相结合，才能在重视整合解决方案和切实患者获益的市场中赢得胜利。

重点评估2025年关税调整如何改变整形外科软组织修復领域的筹资策略、供应链韧性和采购行为。

2025年关税的实施和贸易政策的调整给整形外科软组织修復价值链中的相关人员带来了新的挑战。关税影响进口零件和成品的成本结构，进而波及供应商谈判、定价策略和医院采购流程。为此，製造商被迫重新审视其采购布局，加快本地供应商的资格认证，并在某些情况下重新设计零件，以使用国产材料或性能相当的替代材料。

因此，供应链韧性已成为一项策略重点。各公司正在实现供应商多元化，并建立库存缓衝以缓解短期中断。同时，采购部门正在仔细审查总成本，优先考虑原材料来源的透明度，并寻求长期合约安排以稳定供应和价格波动。临床医生和监管团队也参与其中，因为材料替代会引发额外的检验和潜在的临床可比性考虑。

重要的是，关税上调凸显了监管路径、关税分类和商业策略之间的相互依存关係。中期来看，应对关税限制最直接的措施是注重可製造性设计和供应商自动化，以在确保临床性能标准的同时保护净利率。

将产品设计、临床适应症、终端用户动态、手术技术和材料科学与产品采纳和商业化路径联繫起来的高解析度细分洞察

细分市场层面的洞察揭示了不同产品、应用、终端用户、手术方法和材料组合的差异化驱动因素和应用障碍，为制定有针对性的策略提供了细緻的基础。按产品类型划分，贴片、支架、缝合锚钉和缝线各自占据不同的临床应用领域和商业性管道。贴片用于生物覆盖和加固，分为细胞真皮基质贴片、胶原蛋白贴片和合成贴片。支架可支持组织再生，包括同种异体支架、合成支架和异种移植支架。缝合锚钉提供多种固定方式，例如全缝线锚钉、生物可吸收锚钉和金属锚钉。缝线包括棒状缝线、编织缝线和单丝缝线，具有不同的操作性和强度特性。

无论临床医生进行的是跟腱修復、前十字韧带修復、半月软骨修復还是肩旋板修復，每种应用都需要特定的固定强度、潜在的生物增强和器械相容性组合，从而导致不同的手术流程。终端用户，例如门诊手术中心、医院和专科诊所，其采购週期、资金限制和临床工作流程预期各不相同，这些因素都体现在产品定位和销售策略中。就手术类型而言，关节镜、微创手术和开放性手术对器械和培训的要求各不相同，这会影响锚钉、缝线支撑锚钉系统和增强材料的普及程度。

材料的选择仍然是决定临床疗效和监管路径的核心因素。生物可吸收聚合物（如PGA、PLGA和PLLA）常用于避免长期植入；生物材料（如胶原蛋白和透明质酸）用于促进癒合；金属（如不銹钢和钛）提供较高的初始机械强度；不可吸收聚合物（如聚酯和超高分子量聚乙烯）则提供持久的固定效果。这些细分领域的差异影响研发团队和商业团队的价值提案、证据要求和商业化策略。

全面的区域分析重点阐述了美洲、欧洲、中东和非洲以及亚太地区的趋势将如何影响临床应用、监管和商业策略。

区域动态影响临床实践模式、管理体制、报销方式和供应链，为市场参与企业带来不同的机会和挑战。在美洲，高手术量、完善的器械註册体係以及对临床结果的关注，推动了对具有可靠比较证据和成本效益论证的器械的需求。向门诊病人治疗的转变尤其显着，这种转变正在影响器械设计，使其更偏好精简的器械和更快的学习曲线。

在欧洲、中东和非洲，法规环境的差异和报销机制的多样性使得企业必须制定量身定制的打入市场策略。在某些地区，价格压力和集中采购机制有利于那些能够展现明显预算优势或临床差异化的解决方案。同时，该地区的新兴市场为企业提供了以成本效益为导向的产品调整和培训合作的机会。在亚太地区，微创手术的快速普及和对本地製造能力的投资尤其显着，扩大了该地区对临床研究的贡献。供应链本地化和与区域经销商合作是应对监管时限和物流问题的常见策略倡议。在所有地区，跨境贸易政策、不断变化的报销机制以及临床医生培训计划将继续影响企业资源的分配方式和商业性工作的优先顺序。

深入的竞争分析，重点在于阐述产品系列、证据项目、伙伴关係和营运绩效如何驱动差异化和商业性成功。

整形外科软组织修復领域的竞争格局呈现出成熟器材製造商与敏捷创新者并存的局面，它们透过材料科学、临床证据包和生态系统支援服务来脱颖而出。大型企业在产品性能、易用性和可重复的临床结果方面展开竞争，而新参与企业则往往专注于利基产品创新、经济高效的替代材料以及支持手术规划和培训的数位化工具。策略伙伴关係、分销联盟和有针对性的收购是获取互补技术和拓展地域覆盖范围的常用手段。

整合了锚钉、缝合系统和生物补片的产品系列往往能从交叉销售机会和深入的临床合作中获益。此外，投资临床试验和真实世界证据收集已成为支持医院处方和与支付方谈判的必要竞争手段。从商业角度来看，高效率的生产製造、品质系统和供应链透明度是影响合约谈判和与医疗系统建立长期合作关係的关键差异化因素。销售团队必须将销售讯息与基于证据的提案主张保持一致，并预测临床医生的培训需求，以推动新技术快速普及。

为领导者提供切实可行的建议，帮助他们整合证据、供应链韧性和客製化商业化策略，从而在整形外科软组织修復市场中获得竞争优势。

为了在整形外科软组织修復领域获得可持续的竞争优势，产业领导者应采取多管齐下的策略，整合临床证据的累积、供应链的韧性以及精准的商业化。首先，应优先开发可靠的对比临床数据和真实世界结果，包括修復的持久性、再次手术率以及患者报告的功能改善。其次，应投资于供应链多元化和本地供应商资格认证，以降低贸易成本压力，并提高对临床需求波动的应对力。

同时，我们将调整产品组合和培训计划，以满足门诊手术中心、医院和专科诊所的需求，并根据不同终端使用者对成本、易用性和支援的不同需求，调整市场区隔策略。我们强调模组化产品平台，使其能够快速适应关节镜、微创手术和开放式手术，从而扩展我们可应用的临床案例倡议。在材料方面，我们将平衡生物可吸收性和生物技术与保持机械可靠性的选项，并准备好用对比实验室和临床数据来佐证材料选择。

最后，寻求有针对性的伙伴关係关係，以拓展区域分销管道，并考虑与医疗系统开展基本契约试点项目，以证明整体治疗效果的提升。这些综合措施能够帮助领导者应对监管变化、与收费相关的成本压力以及不断变化的临床医生期望，同时加速产品推广和商业性成功。

透过严格的混合方法研究框架检验可操作的见解，该框架结合了临床访谈、监管研究、文件分析和贸易政策评估。

本分析的调查方法结合了结构化的初步研究、二次研究和文献综述、监管申报审查以及比较性临床证据评估，以确保获得可靠且可操作的见解。初步研究包括对骨科医生、供应链负责人、医院采购专业人员和监管专家的访谈，以了解他们对器械性能、推广障碍和采购标准的观点。这些定性数据与同行评审的临床研究、监管核准和公开的手术基准进行交叉比对，以检验观察到的趋势并为临床结论提供背景资讯。

次要研究包括材料科学文献、手术技术指南和政策文件，这些文献阐明了可吸收聚合物、生物材料、金属和不可吸收聚合物的性能特征，以及跟腱、前十字韧带、半月软骨和肩迴旋肌修復的手术注意事项。此外，我们还进行了供应链和贸易政策分析，以评估近期关税措施的营运影响并确定策略性缓解途径。在整个研究过程中，我们强调跨领域检验，以确保商业性建议基于临床实际情况和监管可行性。

必要时，我们对定性结论进行了敏感性检验，并透过后续访谈和/或查阅相关文献来解决分歧。这种混合方法为决策者提供了切实可行的见解，帮助他们协调产品开发、临床证据策略和上市计划。

简明扼要地总结了材料创新、临床证据的重要性以及成功进行整形外科软组织修復所需的操作韧性之间的整合。

材料和固定技术的创新正在再形成临床实践，报销机制和医疗环境的转变正在重新定义预期价值，而贸易政策的动态正在推动策略性供应链应对措施。这些因素共同促使製造商寻求一种整合方法，将可证实的临床效益与切实可行的商业性执行相结合。临床数据和真实世界证据将继续在推动医院采纳和实现有利的采购结果方面发挥核心作用，而支持多种外科手术的适应性产品设计将扩大临床效用和市场覆盖范围。

此外，关税主导采购经济的调整凸显了积极的供应商策略和以製造为导向的设计倡议的必要性，这些措施旨在保持性能的同时控製成本。在商业性，针对门诊手术中心、医院和专科诊所等不同市场管道的细分市场推广策略，对于加速产品普及和确保优先供应商地位至关重要。最后，随着支付模式向价值和结果导向支付模式转变，那些投资于临床医生教育、精简设备以及强调以患者为中心的循证医学证据的公司，将更有可能获得持续的市场认可。

最后，该领域为那些能够将技术卓越性、临床检验和营运韧性相结合，从而提供满足改善患者预后和提高设施效率这两大迫切需求的解决方案的组织提供了重要的机会。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将生物支架与先进水凝胶载体结合用于肌腱修復
  • 开发用于即时监测术后软组织癒合的可穿戴感测器
  • 利用3D列印患者特异性锚钉改善肩迴旋肌修復效果
  • 增强型微创关节镜手术器械，整合式流体管理系统
  • 加强医疗设备公司和生技公司在生长因子疗法领域的合作
  • 膝关节韧带重组中缝合带技术的应用日益增多
  • 扩增实境手术导引的出现，为精准软组织修復定位提供了可能。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 按产品类型分類的整形外科软组织修復市场

  • 修补
    • 无细胞真皮基质
    • 胶原蛋白蛋白贴片
    • 合成补丁
  • 鹰架
    • 同种异体支架
    • 合成支架
    • 异种移植支架
  • 缝合锚
    • 全缝合锚
    • 生物可吸收锚
    • 金属锚栓
  • 缝合线
    • 倒刺缝合线
    • 编织缝合线
    • 单丝缝线

第九章 按应用分類的整形外科软组织修復市场

  • 跟腱修復
  • 前十字韧带修復
  • 半月软骨修復
  • 肩旋板修復

第十章 按最终使用者分類的整形外科软组织修復市场

  • 门诊手术中心
  • 医院
  • 专科诊所

第十一章 依手术类型分類的整形外科软组织修復市场

  • 关节镜
  • 微创
  • 打开

第十二章整形外科软组织修復材料市场

  • 生物可吸收聚合物
    • PGA
    • PLGA
    • 聚乳酸
  • 生物材料
    • 胶原蛋白
    • 玻尿酸
  • 金属
    • 不銹钢
    • 钛
  • 不可吸收聚合物
    • 聚酯纤维
    • 超高分子量聚乙烯

第十三章 各地区整形外科软组织修復市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章整形外科软组织修復市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国整形外科软组织修復市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • DePuy Synthes, Inc.
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • Smith & Nephew plc
    • Arthrex, Inc.
    • ConMed Corporation
    • Integra LifeSciences Holdings Corporation
    • DJO Global, LLC
    • RTI Surgical Holdings, Inc.
    • Tissue Regenix Group plc
Product Code: MRR-ED54C46E8E67

The Orthopedic Soft Tissue Repair Market is projected to grow by USD 23.53 billion at a CAGR of 16.18% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.08 billion
Estimated Year [2025] USD 8.24 billion
Forecast Year [2032] USD 23.53 billion
CAGR (%) 16.18%

An introductory framework that orients executives to clinical drivers, product families, and commercial levers shaping the orthopedic soft tissue repair ecosystem

This executive summary provides a focused introduction to the contemporary orthopedic soft tissue repair environment, emphasizing the clinical, technological, and commercial forces reshaping care pathways. Over the past decade, clinicians and manufacturers have steadily aligned around materials science, minimally invasive techniques, and biologically active constructs, leading to a more nuanced understanding of repair strategies across tendon and ligament pathologies. The introduction frames the scope of the report by outlining the principal product families, surgical approaches, and end-user settings that determine adoption dynamics and procurement priorities.

Recognizing the interconnected nature of clinician preference, reimbursement drivers, and device innovation, the introduction situates readers to appreciate why certain materials and anchor designs have gained prominence while other solutions are undergoing iterative refinement. This orientation clarifies the interplay between clinical evidence development and commercial execution, underscoring how differentiated clinical outcomes and ease of use influence hospital purchasing committees and ambulatory surgical center contracts. Consequently, strategic leaders will find this introduction useful as a roadmap to the more detailed analysis that follows, enabling targeted exploration of product-level features, application-specific considerations, and regional regulatory contexts.

In sum, the opening section lays out the essential technical vocabulary and market structure that decision-makers need to interpret subsequent insights on competitive positioning, regulatory shifts, and channel strategies for orthopedic soft tissue repair.

A concise analysis of technological, clinical, and commercial inflection points driving rapid evolution in orthopedic soft tissue repair practice and procurement

The landscape for orthopedic soft tissue repair is undergoing transformative shifts driven by converging advances in biomaterials, surgical technique, and value-based care models. Innovation in scaffold chemistry and biologic augmentation has expanded clinical options, while concurrent improvements in suture anchor mechanics and minimally invasive instrumentation have reduced intraoperative complexity. These technological advances are matched by evolving clinician expectations: shorter operating times, reproducible fixation strength, and materials that promote native tissue integration are increasingly non-negotiable attributes for adoption.

Moreover, the changing reimbursement environment and emphasis on ambulatory care pathways are incentivizing solutions that deliver consistent outcomes with lower total episode costs. As a result, manufacturers are prioritizing evidence generation focused on comparative effectiveness and real-world outcomes to support formulary inclusion and hospital credentialing. Meanwhile, supply chain considerations and device consolidation among hospital groups are prompting commercial teams to rethink value propositions and contract strategies.

Taken together, these shifts are catalyzing a move from single-feature competition to comprehensive ecosystem plays that bundle device performance, clinical training, and outcomes support. For manufacturers and health system leaders, the imperative is clear: align product innovation with robust clinical data and pragmatic economic narratives to win in a market that now prizes integrated solutions and demonstrable patient benefit

A focused assessment of how 2025 tariff adjustments are reshaping sourcing strategies, supply chain resilience, and procurement behaviors across the orthopedic soft tissue repair sector

The imposition of tariffs and trade policy adjustments in 2025 has introduced a new layer of complexity for stakeholders engaged in the orthopedic soft tissue repair value chain. Tariffs affect cost structures for imported components and finished devices, reverberating through supplier negotiations, pricing strategies, and hospital procurement processes. In response, manufacturers have been forced to reexamine sourcing footprints, accelerate local supplier qualification, and, in some instances, redesign components to rely on domestically produced feedstock or alternative materials with comparable performance characteristics.

Consequently, supply chain resilience has become a strategic priority. Companies are diversifying supplier bases and increasing inventory buffers to mitigate near-term disruption. At the same time, purchasing organizations are scrutinizing total landed cost, emphasizing transparency around input origin, and exploring longer-term contracting arrangements to stabilize supply and pricing volatility. Clinicians and regulatory teams are also engaged, as material substitutions trigger additional validation and potential clinical comparability exercises.

Importantly, tariffs have highlighted the interdependence of regulatory pathways, customs classifications, and commercial strategy; therefore, cross-functional coordination between compliance, procurement, and commercial teams is now essential. In the medium term, the clearest response to tariff-driven constraints is an intensified focus on design for manufacturability and supplier automation to preserve margins while maintaining clinical performance standards

High-resolution segmentation insights that link product design, clinical indication, end-user dynamics, surgical technique, and material science to adoption and commercialization pathways

Segment-level insights reveal differentiated drivers and adoption barriers across products, applications, end users, surgical approaches, and material sets, offering a granular basis for targeted strategy development. By product type, patches, scaffolds, suture anchors, and sutures each occupy distinct clinical niches and commercial channels: patches are employed for biological coverage and augmentation and can be categorized into acellular dermal matrix, collagen patches, and synthetic patches; scaffolds support tissue in-growth and exist as allograft scaffolds, synthetic scaffolds, and xenograft scaffolds; suture anchors provide fixation options that include all-suture anchors, bioabsorbable anchors, and metal anchors; while sutures encompass barbed sutures, braided sutures, and monofilament sutures with differing handling and strength profiles.

Across applications, procedural requirements vary as clinicians manage Achilles tendon repair, anterior cruciate ligament repair, meniscus repair, and rotator cuff repair, each demanding specific combinations of fixation strength, biological augmentation potential, and instrumentation compatibility. End users such as ambulatory surgical centers, hospitals, and specialty clinics demonstrate different procurement cycles, capital constraints, and clinical workflow expectations that inform product positioning and sales approaches. Regarding surgery type, arthroscopic, minimally invasive, and open procedures have diverging instrumentation needs and training demands, thereby influencing adoption curves for anchors, anchors-with-suture systems, and augmentation materials.

Material selection remains a core determinant of clinical performance and regulatory pathway. Bioabsorbable polymers including PGA, PLGA, and PLLA are often chosen to avoid long-term implant presence, biological materials such as collagen and hyaluronic acid are leveraged to enhance healing, metals like stainless steel and titanium deliver high initial mechanical strength, and nonabsorbable polymers including polyester and ultra-high-molecular-weight polyethylene provide durable fixation. These segmentation distinctions collectively shape value propositions, evidence requirements, and commercialization tactics for developers and commercial teams

Comprehensive regional analysis that delineates how Americas, Europe Middle East & Africa, and Asia-Pacific trends uniquely shape clinical adoption, regulation, and commercial strategy

Regional dynamics influence clinical practice patterns, regulatory regimes, reimbursement approaches, and supply chain considerations, creating varied opportunities and challenges for market participants. In the Americas, procedural volumes, established device registries, and a strong emphasis on clinical outcomes drive demand for devices supported by robust comparative evidence and cost-effectiveness narratives. Transitioning care to outpatient settings is particularly pronounced, and this shift influences device design preferences toward streamlined instrumentation and rapid learning curves.

In Europe, Middle East & Africa, heterogeneous regulatory environments and varied reimbursement mechanisms necessitate tailored market entry strategies; pricing pressures and centralized procurement in some jurisdictions favor solutions that demonstrate clear budgetary advantages or clinical differentiation. Meanwhile, emerging markets in the region present opportunities for cost-effective product adaptations and training partnerships. In the Asia-Pacific area, rapid adoption of minimally invasive techniques and investments in local manufacturing capacity are notable, and regional clinical research contributions are growing. Supply chain localization and partnerships with regional distributors are common strategic responses to address regulatory timelines and logistics. Across all regions, cross-border trade policies, reimbursement evolution, and clinician training programs will continue to shape where and how companies prioritize resource allocation and commercial efforts

Insightful competitive analysis highlighting how product portfolios, evidence programs, partnerships, and operational excellence drive differentiation and commercial traction

Competitive dynamics in orthopedic soft tissue repair reflect a mix of established device manufacturers and nimble innovators, with differentiation driven by material science, clinical evidence packages, and ecosystem support services. Leading players compete on product performance, ease of use, and the ability to demonstrate reproducible clinical outcomes, while newer entrants often focus on niche product innovations, cost-effective material alternatives, or digital tools that support surgical planning and training. Strategic partnerships, distribution alliances, and targeted acquisitions have been common approaches to gain access to complementary technologies or to broaden geographic reach.

Product portfolios that integrate anchors, suture systems, and biologic patches tend to benefit from cross-selling opportunities and deeper clinical engagement, whereas companies specializing in a single product family must emphasize clinical superiority or cost advantages to carve out sustainable positions. Additionally, investment in clinical studies and real-world evidence collection has become a competitive necessity to support hospital formulary placements and payer negotiations. Operationally, efficient manufacturing, quality systems, and supply chain transparency are differentiators that affect contract negotiations and long-term relationships with health systems. For commercial teams, the imperative is to align sales messaging with evidence-based value propositions and to anticipate clinician training needs that facilitate rapid uptake of new technologies

Actionable recommendations for leaders to integrate evidence, supply chain resilience, and tailored commercialization to outperform in orthopedic soft tissue repair markets

Industry leaders should adopt multi-dimensional strategies that integrate clinical evidence generation, supply chain resilience, and focused commercialization to capture durable advantage in orthopedic soft tissue repair. First, prioritize the development of robust comparative clinical data and real-world outcomes that speak to repair durability, reoperation rates, and patient-reported functional gains; these data underpin reimbursement discussions and hospital procurement decisions. Second, invest in supply chain diversification and local supplier qualification to reduce exposure to trade-induced cost pressures and to enhance responsiveness to clinical demand fluctuations.

In parallel, tailor go-to-market initiatives by aligning product configurations and training programs with the needs of ambulatory surgical centers, hospitals, and specialty clinics, recognizing that each end-user segment values different combinations of cost, ease of use, and support. Emphasize modular product platforms that allow rapid adaptation to arthroscopic, minimally invasive, and open techniques, thereby expanding the addressable clinical use cases. From a materials perspective, balance the adoption of bioabsorbable and biological technologies with options that maintain mechanical reliability, and be prepared to substantiate material selections through comparative laboratory and clinical data.

Finally, pursue targeted partnerships for regional distribution and consider value-based contracting pilots with health systems to demonstrate total episode improvements. These integrated actions will position leaders to respond to regulatory shifts, tariff-related cost pressures, and evolving clinician expectations while accelerating adoption and commercial success

A rigorous mixed-methods research framework combining primary clinical interviews, regulatory review, materials analysis, and trade policy assessment to validate actionable insights

The research methodology underpinning this analysis combines structured primary interviews, secondary literature synthesis, device regulatory filings review, and comparative clinical evidence appraisal to ensure robust and actionable insights. Primary inputs include interviews with orthopedic surgeons, supply chain leaders, hospital procurement professionals, and regulatory experts to capture frontline perspectives on device performance, adoption barriers, and purchasing criteria. These qualitative data were triangulated with peer-reviewed clinical studies, regulatory approvals, and publicly available procedural benchmarks to validate observed trends and to contextualize clinical claims.

Secondary research encompassed material science literature, surgical technique guides, and policy documents that illuminate the performance characteristics of bioabsorbable polymers, biological materials, metals, and nonabsorbable polymers, as well as procedural considerations for Achilles tendon, ACL, meniscus, and rotator cuff repairs. Additionally, supply chain and trade policy analyses were performed to assess the operational implications of recent tariff actions and to identify strategic mitigation pathways. Throughout the research process, emphasis was placed on cross-functional validation to ensure that commercial recommendations are grounded in clinical reality and regulatory feasibility.

Where appropriate, sensitivity checks were applied to qualitative assertions, and discrepancies were resolved through follow-up interviews or targeted literature reviews. This mixed-methods approach ensures that the findings are practical for decision-makers seeking to align product development, clinical evidence strategies, and go-to-market plans

A concise synthesis highlighting the convergence of materials innovation, clinical evidence imperatives, and operational resilience required to succeed in orthopedic soft tissue repair

The conclusion synthesizes core themes: innovation in materials and fixation technologies is reshaping clinical practice, reimbursement and care setting transitions are redefining value expectations, and trade policy dynamics are prompting strategic supply chain responses. Together, these forces require manufacturers to pursue an integrated approach that couples demonstrable clinical benefit with pragmatic commercial execution. Clinical data and real-world evidence remain central to unlocking hospital adoption and favorable procurement outcomes, while adaptable product designs that support multiple surgical techniques expand clinical utility and market reach.

Moreover, the tariff-driven adjustments to sourcing economics underscore the need for proactive supplier strategies and design-for-manufacturing initiatives that preserve performance while controlling costs. Commercially, segment-specific go-to-market motions-tailored for ambulatory surgical centers versus hospitals or specialty clinics-will be critical to accelerate uptake and to secure preferred vendor status. Finally, companies that invest in clinician education, streamlined instrumentation, and evidence that highlights patient-centered outcomes will be positioned to capture sustained adoption as payment models emphasize value and outcomes.

In closing, the sector presents meaningful opportunities for organizations that can harmonize technical excellence, clinical validation, and resilient operations, thereby delivering solutions that meet the dual imperatives of improved patient outcomes and institutional efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of biologic scaffolds with advanced hydrogel carriers for tendon regeneration
  • 5.2. Development of wearable sensors for real-time monitoring of post-operative soft tissue healing
  • 5.3. Adoption of 3D-printed patient-specific anchors for improved rotator cuff repair outcomes
  • 5.4. Expansion of minimally invasive arthroscopic instruments with integrated fluid management systems
  • 5.5. Increased collaboration between medical device firms and biotech companies for growth factor therapies
  • 5.6. Rising utilization of suture tape technologies in knee ligament reconstruction procedures
  • 5.7. Emergence of augmented reality surgical navigation for precise soft tissue repair placements

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Orthopedic Soft Tissue Repair Market, by Product Type

  • 8.1. Patches
    • 8.1.1. Acellular Dermal Matrix
    • 8.1.2. Collagen Patches
    • 8.1.3. Synthetic Patches
  • 8.2. Scaffolds
    • 8.2.1. Allograft Scaffolds
    • 8.2.2. Synthetic Scaffolds
    • 8.2.3. Xenograft Scaffolds
  • 8.3. Suture Anchors
    • 8.3.1. All-Suture Anchors
    • 8.3.2. Bioabsorbable Anchors
    • 8.3.3. Metal Anchors
  • 8.4. Sutures
    • 8.4.1. Barbed Sutures
    • 8.4.2. Braided Sutures
    • 8.4.3. Monofilament Sutures

9. Orthopedic Soft Tissue Repair Market, by Application

  • 9.1. Achilles Tendon Repair
  • 9.2. Anterior Cruciate Ligament Repair
  • 9.3. Meniscus Repair
  • 9.4. Rotator Cuff Repair

10. Orthopedic Soft Tissue Repair Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Specialty Clinics

11. Orthopedic Soft Tissue Repair Market, by Surgery Type

  • 11.1. Arthroscopic
  • 11.2. Minimally Invasive
  • 11.3. Open

12. Orthopedic Soft Tissue Repair Market, by Material

  • 12.1. Bioabsorbable Polymers
    • 12.1.1. PGA
    • 12.1.2. PLGA
    • 12.1.3. PLLA
  • 12.2. Biological Material
    • 12.2.1. Collagen
    • 12.2.2. Hyaluronic Acid
  • 12.3. Metal
    • 12.3.1. Stainless Steel
    • 12.3.2. Titanium
  • 12.4. Nonabsorbable Polymers
    • 12.4.1. Polyester
    • 12.4.2. UHMWPE

13. Orthopedic Soft Tissue Repair Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Orthopedic Soft Tissue Repair Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Orthopedic Soft Tissue Repair Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. DePuy Synthes, Inc.
    • 16.3.2. Stryker Corporation
    • 16.3.3. Zimmer Biomet Holdings, Inc.
    • 16.3.4. Smith & Nephew plc
    • 16.3.5. Arthrex, Inc.
    • 16.3.6. ConMed Corporation
    • 16.3.7. Integra LifeSciences Holdings Corporation
    • 16.3.8. DJO Global, LLC
    • 16.3.9. RTI Surgical Holdings, Inc.
    • 16.3.10. Tissue Regenix Group plc

LIST OF FIGURES

  • FIGURE 1. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ORTHOPEDIC SOFT TISSUE REPAIR MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ORTHOPEDIC SOFT TISSUE REPAIR MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ORTHOPEDIC SOFT TISSUE REPAIR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACELLULAR DERMAL MATRIX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACELLULAR DERMAL MATRIX, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACELLULAR DERMAL MATRIX, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACELLULAR DERMAL MATRIX, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACELLULAR DERMAL MATRIX, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACELLULAR DERMAL MATRIX, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN PATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN PATCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN PATCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN PATCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN PATCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN PATCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC PATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC PATCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC PATCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC PATCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC PATCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC PATCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALLOGRAFT SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALLOGRAFT SCAFFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALLOGRAFT SCAFFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALLOGRAFT SCAFFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALLOGRAFT SCAFFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALLOGRAFT SCAFFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY XENOGRAFT SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY XENOGRAFT SCAFFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY XENOGRAFT SCAFFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY XENOGRAFT SCAFFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY XENOGRAFT SCAFFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY XENOGRAFT SCAFFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALL-SUTURE ANCHORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALL-SUTURE ANCHORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALL-SUTURE ANCHORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALL-SUTURE ANCHORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALL-SUTURE ANCHORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALL-SUTURE ANCHORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE ANCHORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE ANCHORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE ANCHORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE ANCHORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE ANCHORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE ANCHORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL ANCHORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL ANCHORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL ANCHORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL ANCHORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL ANCHORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL ANCHORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BARBED SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BARBED SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BARBED SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BARBED SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BARBED SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BARBED SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BRAIDED SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BRAIDED SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BRAIDED SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BRAIDED SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BRAIDED SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BRAIDED SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MONOFILAMENT SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MONOFILAMENT SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MONOFILAMENT SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MONOFILAMENT SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MONOFILAMENT SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MONOFILAMENT SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACHILLES TENDON REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACHILLES TENDON REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACHILLES TENDON REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACHILLES TENDON REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACHILLES TENDON REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACHILLES TENDON REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MENISCUS REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MENISCUS REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MENISCUS REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MENISCUS REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MENISCUS REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MENISCUS REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ROTATOR CUFF REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ROTATOR CUFF REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ROTATOR CUFF REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ROTATOR CUFF REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ROTATOR CUFF REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ROTATOR CUFF REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ARTHROSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ARTHROSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ARTHROSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ARTHROSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ARTHROSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ARTHROSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY OPEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY OPEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY OPEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY OPEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY OPEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PGA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PGA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PGA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PGA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PGA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PGA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLGA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLGA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLGA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLGA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLGA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLGA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLLA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLLA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLLA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLLA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLLA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLLA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HYALURONIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HYALURONIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HYALURONIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HYALURONIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY TITANIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY TITANIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY TITANIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY TITANIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY POLYESTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY POLYESTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY POLYESTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY POLYESTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY UHMWPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY UHMWPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY UHMWPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY UHMWPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY UHMWPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY UHMWPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2025-2032 (USD MILLION)
  • TABLE 293. AMERI